课题基金 / 基金详情

Pathological analysis of ribosomal protein S19 deficient Diamond-Blackfan anemia

Pathological analysis of ribosomal protein S19 deficient Diamond-Blackfan anemia
核糖体蛋白S19缺陷型Diamond-Blackfan贫血的病理分析
批准号:
17591021
负责人:
HAMAGUCHI Isao
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

HAMAGUCHI Isao的其他基金

相似基金

相关文献

中文摘要
翻译
为了分析RPS19突变的钻石-黑粉贫血(DBA)的病理机制,我们开发了12种点突变的RPS19表达载体。将突变基因导入K562细胞,12个载体中有11个载体不能表达突变的RPS19蛋白。由于蛋白小体抑制剂MG 132挽救了蛋白质的表达,因此蛋白质的消亡是由蛋白质小体中的消化引起的。RPS19突变的DBA患者被认为缺乏RPS19。当针对RPS19基因的siRNA抑制RPS19基因在K562细胞中的表达时,K562细胞停止增殖而不发生凋亡。在这些细胞中,p21和p57的表达增加,Rb被磷酸化,Ki 67/Hoechst 33342染色显示它们进入G0期。转导细胞表现为G0期停滞,红系祖细胞(CD34+CD71HighCD45RA-)严重缺失,RPS19突变DBA是由RPS19蛋白表达水平引起的,其主要机制是造血干细胞或早期红系祖细胞发生G0期停滞。
英文摘要
In order to analyze the pathology of the RPS19 mutated Diamond-Blackfan anemia (DBA), we have developed the 12 kinds of one point mutated RPS 19 expression vectors. When the mutated genes were transfected in K562 cells, 11 out of 12 vectors could not produce the mutated RPS19 protein. Since the proteosome inhibitor, MG 132 rescued the protein expression, the protein extinctions were caused by digestion in the proteosome. From these results showed that RPS 19 mutated DBA patients are thought to lack of RPS19.When the expression of RPS19 genes were repressed by siRNA against RPS19 gene in K562 cells, they stopped proliferating without apoptosis. In these cells, the expression of p21 and p57 were increased, and Rb were phospholyrated, and Ki 67/Hoechst 33342 staining showed that they went into the G0 arrest.Furthermore, human CD34 positive cells were transduced by the lentiviral vector that contained the siRNA sequence against RPS19. The transduced cells showed G0 arrest, and the severe defect of the erythroid progenitor fraction (CD34+CD71highCD45RA-).Together with these results, RPS19 mutated DBA are caused by the expression level of RPS19 protein, and the main mechanism of this disease is G0 arrest in the hematopoietic stem cells or early erythroid progenitors.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival.
Tie2 受体的缺失会损害胚胎干细胞来源的内皮细胞的存活,但不会损害造血细胞的存活。
DOI: --
发表时间: 2006
期刊: Blood 107
影响因子: --
作者: [Hamaguchi I., Morisada T., Azuma M., Murakami K., Kuramitsu M., Mizukami T., Ohbo K., Yamaguchi K., Oike Y., Dumont DJ., Suda T.]
通讯作者: Suda T.
CTX family cell adhesion molecule, JAM4, expresses in stem cell- and progenitor cell populations of both male germ cell and hematopoietic cell lineages.
CTX 家族细胞粘附分子 JAM4 在雄性生殖细胞和造血细胞谱系的干细胞和祖细胞群中表达。
DOI: --
发表时间: 2006
期刊: Mol. Cell. Biol. 24巻
影响因子: --
作者: [Nagamatsu G, Ohmura M, Mizukami T, Hamaguchi I, Hirabayashi S, Yoshida S, Hata Y, Suda T, Ohbo K.]
通讯作者: Ohbo K.
CTX family cell adhesion molecule, JAM4, expresses in stem cell- and progenitor cell-populations of both male germ cell and hematopoietic cell lineage
CTX 家族细胞粘附分子 JAM4 在雄性生殖细胞和造血细胞谱系的干细胞和祖细胞群中表达
DOI: --
发表时间: 2006
期刊: Mol. Cell. Biol 26
影响因子: --
作者: [Shimada Y, Inomata M, Suzuki H, Hayashi M, Waheed AA, Ohno-Iwashita Y, 鈴木英紀, 鈴木 英紀(分担執筆), 鈴木英紀(分担執筆), 鈴木英紀(分担執筆), Isao Hamaguchi, Isao Hamaguchi et al., Nakagawa M et al., Go Nagamatsu et al.]
通讯作者: Go Nagamatsu et al.
Two vaccine toxicity-related genes Agp and Hpx could prove useful fr pertussis vaccine safety control
两种疫苗毒性相关基因 Agp 和 HPx 可能对百日咳疫苗安全控制有用
DOI: --
发表时间: 2007
期刊: Vaccine 25
影响因子: --
作者: [Shimada Y, Inomata M, Suzuki H, Hayashi M, Waheed AA, Ohno-Iwashita Y, 鈴木英紀, 鈴木 英紀(分担執筆), 鈴木英紀(分担執筆), 鈴木英紀(分担執筆), Isao Hamaguchi]
通讯作者: Isao Hamaguchi
共 9 条
    Identification and functional analysis of ATL cancer stem cells using a humanized mice
    • 批准号:
      24591414
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      HAMAGUCHI Isao
    • 依托单位:
    Development of the biomarker for th e clinical diagnosis of Diamond-Blackfan Anemia
    • 批准号:
      21591228
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      HAMAGUCHI Isao
    • 依托单位:
    Development of safety vector for the gene therapy of ribosomal protein S19 deficient Diamond-Blackfan anemia
    国内基金
    核仁小RNA SNORD18B/18C与RPS19互作调控放射诱导DSBs同源重组修复的机制研究
    • 批准号:
      82304083
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      贺俊彦
    • 依托单位:
    RPS19异常相关DBA发病及地塞米松治疗DBA机制的研究
    • 批准号:
      81770112
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2017
    • 负责人:
      安秀丽
    • 依托单位: